# DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

> **NCT02487550** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The First People's Hospital of Changzhou** · enrollment: 1200 (estimated)

## Conditions studied

- Renal Neoplasma

## Interventions

- **BIOLOGICAL:** DC-CIK
- **BIOLOGICAL:** IL-2/IFN-α

## Key facts

- **NCT ID:** NCT02487550
- **Lead sponsor:** The First People's Hospital of Changzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2015-08
- **Primary completion:** 2028-07
- **Final completion:** 2030-07
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2015-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02487550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02487550, "DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02487550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*